| Title |
Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, September 2014
|
| DOI | 10.1001/jama.2014.10707 |
| Pubmed ID | |
| Authors |
Allison W. Kurian, Daphne Y. Lichtensztajn, Theresa H. M. Keegan, David O. Nelson, Christina A. Clarke, Scarlett L. Gomez |
| Abstract |
Bilateral mastectomy is increasingly used to treat unilateral breast cancer. Because it may have medical and psychosocial complications, a better understanding of its use and outcomes is essential to optimizing cancer care. |
X Demographics
The data shown below were collected from the profiles of 151 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 36 | 24% |
| Spain | 8 | 5% |
| Japan | 8 | 5% |
| Canada | 8 | 5% |
| United Kingdom | 4 | 3% |
| Australia | 4 | 3% |
| Peru | 3 | 2% |
| France | 3 | 2% |
| Netherlands | 2 | 1% |
| Other | 11 | 7% |
| Unknown | 64 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 97 | 64% |
| Practitioners (doctors, other healthcare professionals) | 26 | 17% |
| Scientists | 18 | 12% |
| Science communicators (journalists, bloggers, editors) | 10 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| China | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 143 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 14% |
| Student > Ph. D. Student | 20 | 13% |
| Student > Bachelor | 17 | 11% |
| Student > Master | 16 | 11% |
| Other | 13 | 9% |
| Other | 32 | 21% |
| Unknown | 31 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 43% |
| Biochemistry, Genetics and Molecular Biology | 10 | 7% |
| Agricultural and Biological Sciences | 8 | 5% |
| Nursing and Health Professions | 7 | 5% |
| Engineering | 5 | 3% |
| Other | 19 | 13% |
| Unknown | 37 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 781. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2023.
All research outputs
#25,038
of 25,756,531 outputs
Outputs from JAMA: Journal of the American Medical Association
#582
of 36,792 outputs
Outputs of similar age
#141
of 250,010 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#2
of 377 outputs
Altmetric has tracked 25,756,531 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,792 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,010 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 377 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.